Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
NA
60 participants
INTERVENTIONAL
2025-09-03
2026-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Virtual Reality in Laryngology
NCT05218967
Feasibility Study on an Immersive Virtual Reality Tool in the Treatment of Chronic Low Back Pain
NCT04781465
Virtual Reality Treatment for Adults With Chronic Back Pain
NCT04468074
Reducing Adult Inpatients Anxiety With Virtual Reality Meditation
NCT06234254
Effects and Mechanism of Guided Virtual Reality Autogenic Meditation on ICU Sleep
NCT05196672
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Meditation with VR
Those who receive meditation in immersive virtual reality prior to voice therapy each of the 4 sessions.
Voice therapy
All patients will receive a course of voice therapy as normal.
Meditation
Meditation at the start of each session. (each session is 30 minutes)
Virtual Reality
TRIPP application in the Meta Quest 2 Virtual Reality Headset.
Meditation without VR
Those who receive meditation with verbal guidance only prior to voice therapy each of the 4 sessions.
Voice therapy
All patients will receive a course of voice therapy as normal.
Meditation
Meditation at the start of each session. (each session is 30 minutes)
No Meditation
Those who receive standard voice therapy with no meditation.
Voice therapy
All patients will receive a course of voice therapy as normal.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Voice therapy
All patients will receive a course of voice therapy as normal.
Meditation
Meditation at the start of each session. (each session is 30 minutes)
Virtual Reality
TRIPP application in the Meta Quest 2 Virtual Reality Headset.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Must have availability to participate for entire course of 5 consistent weeks
* Presence of any additional medical condition significantly affecting:
* Respiratory function (e.g., advanced lung disease)
* Laryngeal function (e.g., status-post deep brain stimulation)
* Lingual function
* Velopharyngeal function (e.g., laryngectomy)
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Icahn School of Medicine at Mount Sinai
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Bradley Hoff
Speech-Language Pathologist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bradley R Hoff, MA, CCC-SLP
Role: PRINCIPAL_INVESTIGATOR
Icahn School of Medicine at Mount Sinai, Department of Otolaryngology
Ümit Daşdöğen, Ph.D., CCC-SLP
Role: STUDY_DIRECTOR
Icahn School of Medicine at Mount Sinai, Department of Otolaryngology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mount Sinai Downtown Union Square
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STUDY-24-01217
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.